Endogenous indoleamines demonstrate moderate affinity for I2 binding sites.
Hudson
A L
AL
Psychopharmacology Unit, School of Medical Sciences, University of Bristol, UK. a.l.hudson@bris.ac.uk
Luscombe
S
S
Gouch
R E
RE
Nutt
D J
DJ
Tyacke
R J
RJ
D000376:Agmatine / Q000378:metabolism; D000818:Animals; D001572:Benzofurans / Q000493:pharmacokinetics; D001665:Binding Sites; D001667:Binding, Competitive; D015306:Biogenic Monoamines / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D002462:Cell Membrane / Q000378:metabolism; D005260:Female; D006632:Histamine / Q000378:metabolism; D007093:Imidazoles / Q000493:pharmacokinetics*; D054755:Imidazoline Receptors; D007510:Isatin / Q000378:metabolism; D007700:Kinetics; D008297:Male; D011817:Rabbits; D051381:Rats; D017208:Rats, Wistar; D011955:Receptors, Drug / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D014316:Tritium; D014363:Tryptamines / Q000378:metabolism; D014364:Tryptophan / Q000378:metabolism
C105826:BU 224; D001572:Benzofurans; D015306:Biogenic Monoamines; D007093:Imidazoles; D054755:Imidazoline Receptors; D011955:Receptors, Drug; D014363:Tryptamines; D014316:Tritium; D012701:Serotonin; C030820:tryptamine; D000376:Agmatine; C103723:2-(2-benzofuranyl)-2-imidazoline; D006632:Histamine; D007510:Isatin; D014364:Tryptophan